Skip to main content


Fig. 8 | Cell & Bioscience

Fig. 8

From: Label-free quantitative proteomics identifies transforming growth factor β1 (TGF-β1) as an inhibitor of adipogenic transformation in OP9-DL1 cells and primary thymic stromal cells

Fig. 8

TGF-β1 suppressed rosiglitazone-induced adipogenic transformation in primary TSCs. a The morphology of TSCs and OP9-DL1 cells observed by optical microscope. b TSCs were treated with various concentrations of TGF-β1 for 7 days in the presence of rosiglitazone, and Oil Red O staining was carried out to visualize accumulated lipids. Bars, 50 μM. Rosi rosiglitazone

Back to article page